載入...
Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver disease
Non-alcoholic fatty liver disease (NAFLD) is the most common form of chronic liver disease in the Western world. It is more prevalent in male gender, and with increasing age, obesity, and insulin resistance. Besides weight loss, there are limited treatment options. The use of anti-diabetic medicatio...
Na minha lista:
| 發表在: | World J Hepatol |
|---|---|
| Main Authors: | , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Baishideng Publishing Group Inc
2019
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6669193/ https://ncbi.nlm.nih.gov/pubmed/31388398 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v11.i7.562 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|